Currently it only shows your basic business info. Start adding relevant business details such as description, images and products or services to gain your customers attention by using Boost 360
android app
/
iOS App/ web portal.
{
"products": [
{
"_id": "69f451ed52000f66fe9fdf78",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Thyroxine Sodium 88 mcg",
"description": "Thyroxine Sodium 88mcg – Effective Thyroid Hormone Replacement for Better Daily Health\n\nThyroxine Sodium 88mcg is a widely prescribed thyroid hormone replacement medicine used to treat low thyroid hormone levels. If you are searching for a trusted solution for hypothyroidism, thyroid imbalance, or long-term thyroid support, Thyroxine Sodium 88mcg is commonly recommended by healthcare professionals to restore normal hormone levels and improve overall well-being.\n\nPeople with underactive thyroids often experience tiredness, weight gain, dry skin, low mood, hair thinning, and sluggish metabolism. This medicine helps replace the hormone your thyroid gland is unable to produce in adequate amounts. When taken regularly under medical supervision, it can significantly improve energy, metabolism, and quality of life.\n\nWhat is thyroxine sodium 88 mcg?\n\nThyroxine Sodium 88mcg contains levothyroxine sodium, a synthetic form of thyroxine (T4), which is a natural hormone produced by the thyroid gland. It is used when the body does not make enough thyroid hormone naturally.\n\nThe thyroid gland controls many essential body functions, including:\n\nMetabolism\nEnergy production\nBody temperature\nHeart rate\nDigestion\nBrain function\nSkin and hair health\n\nWhen thyroid hormone levels become low, replacing them with Thyroxine Sodium 88mcg helps restore normal balance.\n\nHow Does Thyroxine Sodium 88mcg Work?\n\nThis medicine supplies synthetic thyroxine hormone to the body. After absorption, it is converted into the active hormone triiodothyronine (T3), which helps regulate metabolism and cellular activity.\n\nBy normalizing thyroid hormone levels, Thyroxine Sodium 88mcg can help:\n\nIncrease energy levels\nImprove concentration\nSupport healthy weight management\nReduce fatigue\nImprove skin and hair condition\nNormalize heart and digestive function\nUses of Thyroxine Sodium 88mcg\n\nDoctors prescribe Thyroxine Sodium 88mcg for several thyroid-related conditions.\n\n1. Hypothyroidism\n\nThe most common use is treatment of underactive thyroid gland.\n\n2. Hashimoto’s Thyroiditis\n\nUsed in autoimmune thyroid disease that leads to reduced hormone production.\n\n3. After Thyroid Surgery\n\nHelps replace hormones when thyroid gland is partially or completely removed.\n\n4. Thyroid Hormone Suppression Therapy\n\nSometimes used in selected thyroid nodules or thyroid cancer management under specialist care.\n\n5. Congenital Thyroid Deficiency\n\nMay be prescribed in certain patients requiring lifelong replacement.\n\nKey Benefits of Thyroxine Sodium 88mcg\n\nChoosing Thyroxine Sodium 88mcg offers several important benefits.\n\nRestores Hormone Balance\n\nReplaces missing thyroid hormone effectively.\n\nImproves Daily Energy\n\nHelps reduce tiredness and sluggishness.\n\nSupports Healthy Metabolism\n\nMay help improve slow metabolism caused by hypothyroidism.\n\nBetter Mood and Focus\n\nMany patients notice improved concentration and mental clarity.\n\nHelps Skin and Hair Health\n\nCan improve dryness, brittle hair, and thinning caused by low thyroid.\n\nTrusted Long-Term Therapy\n\nWidely used globally for long-term thyroid management.\n\nWho May Need Thyroxine Sodium 88mcg?\n\nYour doctor may prescribe Thyroxine Sodium 88mcg if you have symptoms such as:\n\nConstant tiredness\nWeight gain\nFeeling cold often\nDry skin\nHair fall\nSlow heart rate\nConstipation\nDepression or low mood\nBrain fog\nHigh TSH blood test results\n\nOnly take this medicine after proper diagnosis and thyroid testing.\n\nHow to Take Thyroxine Sodium 88mcg\n\nUse exactly as prescribed by your healthcare provider.\n\nGeneral Directions:\nTake once daily, usually in the morning\nTake on an empty stomach with water\nTake 30–60 minutes before breakfast\nSwallow whole tablet\nTake at the same time every day\nDo not skip doses\n\nConsistency is very important for best results.\n\nDosage Information\n\nThyroxine Sodium 88mcg is a specific strength chosen according to your thyroid blood reports, age, body weight, heart health, and treatment response.\n\nNever change dose yourself. Doctors may adjust dosage after repeat TSH, T3, and T4 tests.\n\nCommon Side Effects\n\nWhen dose is correct, side effects are uncommon. If dose is too high, symptoms of excess thyroid hormone may appear.\n\nPossible Side Effects:\nFast heartbeat\nNervousness\nSweating\nTrouble sleeping\nWeight loss\nTremors\nHeadache\nIncreased appetite\n\nContact your doctor if these symptoms occur.\n\nSerious Side Effects\n\nSeek urgent medical attention if you notice:\n\nChest pain\nSevere palpitations\nIrregular heartbeat\nShortness of breath\nSevere anxiety\nFainting\n\nThese may indicate over-replacement or another health issue.\n\nImportant Precautions\n\nBefore taking Thyroxine Sodium 88mcg, tell your doctor if you have:\n\nHeart disease\nHigh blood pressure\nDiabetes\nAdrenal gland disorders\nOsteoporosis\nPregnancy\nKidney disease\nOther chronic conditions\n\nRegular thyroid blood tests are essential during treatment.\n\nDrug Interactions\n\nSome medicines can affect absorption or effectiveness of Thyroxine Sodium 88mcg.\n\nInform your doctor if you take:\n\nCalcium supplements\nIron tablets\nAntacids\nCholesterol medicines\nDiabetes medicines\nBlood thinners\nHormonal medicines\n\nThese may need spacing or dose adjustment.\n\nThyroxine Sodium 88mcg in Pregnancy\n\nThyroid hormone control is very important during pregnancy. Thyroxine Sodium 88mcg is commonly continued during pregnancy under medical supervision, though dose adjustments may be needed.\n\nNever stop thyroid medicine during pregnancy without consulting your doctor.\n\nStorage Instructions\n\nStore tablets properly:\n\nKeep in cool, dry place\nProtect from moisture and sunlight\nKeep away from children\nUse before expiry date\nWhy Buy Thyroxine Sodium 88mcg?\n\nIf you are searching for a reliable thyroid replacement treatment, Thyroxine Sodium 88mcg is a trusted option because it offers:\n\nAccurate hormone replacement\nImproved daily functioning\nBetter energy and metabolism\nLong-term treatment reliability\nDoctor-recommended thyroid support\nTips for Better Thyroid Management\n\nAlong with medicine, follow these habits:\n\nTake tablet daily on time\nAvoid skipping doses\nGet regular TSH tests\nMaintain balanced nutrition\nExercise regularly\nSleep adequately\nFollow doctor review schedule\nFrequently Asked Questions\nIs Thyroxine Sodium 88mcg a lifelong medicine?\n\nMany patients need long-term or lifelong treatment, depending on the cause of hypothyroidism.\n\nHow soon does it start working?\n\nSome people notice improvement within 2–4 weeks, but full benefit may take longer.\n\nCan I stop once I feel better?\n\nNo. Continue unless your doctor changes or stops treatment.\n\nCan it help weight gain from hypothyroidism?\n\nYes, restoring thyroid balance may support metabolism and weight management.\n\nIs testing necessary?\n\nYes, regular blood tests are essential to maintain the correct dose.\n\nWhy Purchase from a Trusted Supplier?\n\nAlways buy Thyroxine Sodium 88mcg from a reliable pharmacy or supplier to ensure:\n\nGenuine product quality\nProper storage conditions\nCorrect strength and packaging\nSafe dispensing\nAuthentic medicine supply\nConclusion\n\nThyroxine Sodium 88mcg is a highly trusted thyroid hormone replacement medicine used to manage hypothyroidism and maintain healthy thyroid balance. It helps improve energy, metabolism, mood, concentration, and overall wellness when taken regularly under medical supervision. ",
"price": 220.0,
"discountamount": 66.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2395,
"imageuri": "https://productimages.withfloats.com/actual/69f451ef054a374f7099f9bd.png",
"tileimageuri": "https://productimages.withfloats.com/tile/69f451ef054a374f7099f9bd.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2026-05-01T07:10:37.49Z",
"updatedon": "2026-05-01T07:43:16Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/thyroxine-sodium-88-mcg/2395",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "THYRORISE 88",
"category": "ENDORIONOLGY",
"tags": [
"thyroxine sodium 88 mcg",
"Thyroxine Sodium 88 mcg price in India",
"Buy Thyroxine Sodium 88 mcg online",
"Thyroxine Sodium 88 mcg tablet supplier",
"Generic Thyroxine Sodium 88 mcg tablets",
"Thyroxine Sodium 88 mcg wholesale price",
"Thyroxine Sodium 88 mcg tablet low price",
"Thyroxine Sodium 88 mcg bulk order",
"Best Thyroxine Sodium 88 mcg manufacturer in India",
"Thyroxine Sodium 88 mcg for thyroid treatment",
"Best price Thyroxine Sodium 88 mcg tablets online"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "698d91909e3c03f732124005",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Remogliflozin Etabonate Tablets 100 mg",
"description": "REMOFLOZIN 100 is an advanced oral antidiabetic medication containing Remogliflozin Etabonate 100 mg as its active pharmaceutical ingredient. This innovative formulation represents a significant breakthrough in the management of Type 2 Diabetes Mellitus, offering patients a novel mechanism of action that works independently of insulin secretion or insulin sensitivity. REMOFLOZIN 100 belongs to the sodium-glucose co-transporter 2 (SGLT2) inhibitors class of medications, which has revolutionized diabetes management by targeting glucose reabsorption in the kidneys rather than affecting pancreatic function or peripheral glucose utilization.\nDeveloped through rigorous scientific research and clinical trials, REMOFLOZIN 100 provides diabetic patients with an effective therapeutic option that not only helps control blood sugar levels but also offers additional cardiovascular and metabolic benefits. Each tablet is precisely formulated to deliver consistent and reliable glycemic control, making it an essential component in the comprehensive management of Type 2 Diabetes.\nHow REMOFLOZIN 100 Works\nThe mechanism of action of REMOFLOZIN 100 is both unique and highly effective. Under normal physiological conditions, the kidneys filter glucose from the blood, but the SGLT2 proteins in the proximal renal tubules reabsorb approximately 90% of this filtered glucose back into the bloodstream. In diabetic patients, this reabsorption continues even when blood glucose levels are elevated, perpetuating hyperglycemia.\nRemogliflozin Etabonate works by selectively inhibiting the SGLT2 proteins in the kidneys, thereby reducing glucose reabsorption and increasing urinary glucose excretion. This insulin-independent mechanism allows the body to eliminate excess glucose naturally through urine, leading to sustained reductions in blood glucose levels. The medication typically begins working within hours of administration, with maximum therapeutic effects observed within several weeks of consistent use.\nPrimary Uses and Indications\nREMOFLOZIN 100 is primarily indicated for:\nManagement of Type 2 Diabetes Mellitus: As monotherapy in patients who cannot tolerate metformin or for whom metformin is contraindicated, and as combination therapy with other antidiabetic agents including metformin, sulfonylureas, or insulin when existing treatment regimens fail to achieve adequate glycemic control.\nGlycemic Control Optimization: For patients requiring additional blood sugar management beyond diet and exercise modifications, REMOFLOZIN 100 helps reduce both fasting plasma glucose and postprandial glucose levels.\nAdjunct to Lifestyle Modifications: The medication works synergistically with dietary modifications and regular physical activity to achieve comprehensive diabetes management and reduce the risk of long-term diabetic complications.\nKey Benefits of REMOFLOZIN 100\nSuperior Glycemic Control\nREMOFLOZIN 100 demonstrates significant efficacy in reducing HbA1c levels, typically achieving reductions of 0.5% to 1.0% when used as monotherapy and even greater reductions when combined with other antidiabetic medications. This improvement in long-term glucose control translates to reduced risk of microvascular complications, including diabetic retinopathy, nephropathy, and neuropathy.\nWeight Management Support\nUnlike many traditional antidiabetic medications that may cause weight gain, REMOFLOZIN 100 is associated with modest weight loss, typically ranging from 2 to 4 kilograms over several months of treatment. This weight reduction occurs due to caloric loss through urinary glucose excretion and may provide additional metabolic benefits for overweight or obese diabetic patients.\nCardiovascular Benefits\nEmerging research on SGLT2 inhibitors suggests potential cardiovascular protective effects, including modest reductions in blood pressure and improvements in various cardiovascular risk markers. These benefits may be particularly valuable for diabetic patients who are at increased risk of cardiovascular disease.\nLow Risk of Hypoglycemia\nBecause REMOFLOZIN 100 works independently of insulin secretion, it carries a minimal risk of hypoglycemia when used as monotherapy. This safety profile makes it particularly suitable for elderly patients or those at higher risk of dangerous low blood sugar episodes.\nRenal Function Considerations\nThe medication may offer nephroprotective benefits by reducing intraglomerular pressure and proteinuria in diabetic patients, potentially slowing the progression of diabetic kidney disease.\nConvenient Once-Daily Dosing\nREMOFLOZIN 100's pharmacokinetic profile allows for convenient once-daily administration, improving patient compliance and treatment adherence.\nPotential Side Effects and Safety Considerations\nWhile REMOFLOZIN 100 is generally well-tolerated, patients should be aware of potential side effects:\nCommon Side Effects\n\nGenital Mycotic Infections: Increased glucose in urine may promote fungal infections, particularly in women\nUrinary Tract Infections: More frequent urination and glucose in urine may increase UTI risk\nIncreased Urination: Polyuria is expected due to the medication's mechanism of action\nThirst: Patients may experience increased thirst due to fluid loss\nDizziness: Particularly when standing up quickly, due to mild blood pressure reductions\n\nSerious but Rare Side Effects\n\nDiabetic Ketoacidosis: Although rare, euglycemic DKA has been reported with SGLT2 inhibitors\nAcute Kidney Injury: Dehydration may affect kidney function in susceptible individuals\nLower Limb Amputation: Some SGLT2 inhibitors have shown increased risk in specific populations\nHypotension: Particularly in patients on diuretics or with compromised cardiovascular function\n\nContraindications and Precautions\nREMOFLOZIN 100 should not be used in patients with type 1 diabetes, severe renal impairment, diabetic ketoacidosis, or those with known hypersensitivity to the drug. Pregnant and breastfeeding women should avoid this medication. Patients should maintain adequate hydration and practice proper genital hygiene to minimize infection risks.\nDosage and Administration Guidelines\nThe standard recommended dose is one REMOFLOZIN 100 tablet taken orally once daily, preferably at the same time each day. The medication can be taken with or without food. Patients should not double doses if they miss a scheduled dose but should take the next dose at the regular time. Dosage adjustments may be necessary based on individual response, renal function, and concomitant medications. Regular monitoring of blood glucose levels, kidney function, and HbA1c is essential for optimal treatment management.\nConclusion\nREMOFLOZIN 100 represents a valuable therapeutic advancement in type 2 diabetes management, offering patients an innovative approach to glycemic control through its unique renal mechanism of action. The medication's ability to reduce blood sugar levels while providing additional benefits such as weight loss, cardiovascular protection, and low hypoglycemia risk makes it an attractive option for many diabetic patients.",
"price": 335.0,
"discountamount": 101.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2301,
"imageuri": "https://productimages.withfloats.com/actual/698d9191cd6033ecce84b352.png",
"tileimageuri": "https://productimages.withfloats.com/tile/698d9191cd6033ecce84b352.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2026-02-12T08:38:40.037Z",
"updatedon": "2026-03-13T11:02:30.281Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//remogliflozin-etabonate-tablets-100-mg/2301",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "REMOFLOZIN 100",
"category": "DIABETIC RANGE",
"tags": [
"Remogliflozin Etabonate 100mg tablets for type 2 diabetes",
"Remogliflozin 100mg oral diabetes medication",
"Remogliflozin Etabonate tablets 100mg prescription",
"Remogliflozin 100 mg SGLT2 inhibitor tablets",
"Remogliflozin Etabonate 100mg diabetes control tablets",
"Buy Remogliflozin 100mg tablets online",
"Remogliflozin Etabonate 100mg pack price",
"Remogliflozin 100mg tablets for blood sugar management"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "694e56c05837f90c86a7eb8c",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "empagliflozin linagliptin and metformin",
"description": "LINALIGIP EMPAMET (Empagliflozin, Linagliptin, and Metformin Hydrochloride ER Tablets) stands out as a comprehensive triple therapy for adults with type 2 diabetes mellitus, combining three synergistic agents to tackle hyperglycemia from multiple angles. This once-daily extended-release formulation simplifies adherence while delivering robust glycemic control, weight management, and cardiovascular protection. Patients often seek it for its convenience in managing blood sugar levels when diet, exercise, and single agents fall short.\n\n\nProduct Description and Composition\nLINALIGIP EMPAMET features Empagliflozin (typically 10-25mg), Linagliptin (5 mg), and Metformin Hydrochloride ER (up to 1000mg) in a single tablet, designed for prolonged release to minimize gastrointestinal upset. Empagliflozin, an SGLT2 inhibitor, blocks glucose reabsorption in the kidneys, promoting its excretion via urine. Linagliptin, a DPP-4 inhibitor, enhances incretin hormones like GLP-1 to boost insulin secretion and suppress glucagon. Metformin ER reduces hepatic glucose production and improves insulin sensitivity without hypoglycemia risk.\n\n\nThis unique blend from Steris Healthcare ensures steady drug delivery over 24 hours, reducing peak-trough fluctuations for stable HbA1c reductions of 1.5-2.0%. The extended-release metformin coats the tablet core, dissolving gradually in the intestines for better tolerability compared to immediate-release forms. Ideal for Indian patients facing rising diabetes prevalence, it addresses insulin resistance, postprandial spikes, and caloric overload holistically.\n\n\nMechanism of Action\nThe triple mechanism targets key diabetes pathways: Empagliflozin inhibits SGLT2 in proximal renal tubules, lowering blood glucose by 70-90g daily through glycosuria, independent of insulin. Linagliptin selectively binds DPP-4, prolonging GLP-1 and GIP activity to stimulate glucose-dependent insulin release from beta cells and curb glucagon-mediated gluconeogenesis. Metformin activates AMPK in hepatocytes, inhibiting gluconeogenesis while enhancing peripheral glucose uptake.\n\n\nSynergy amplifies effects—SGLT2 inhibition provides insulin-independent control, DPP-4 boosts prandial responses, and metformin tackles fasting hyperglycemia—resulting in complementary HbA1c drops without overlapping toxicities. Clinical data show this combination yields superior efficacy over dual therapies, with added osmotic diuresis aiding fluid balance.\n\n\nUses and Indications\nLINALIGIP EMPAMET treats type 2 diabetes in adults, as adjunct to diet and exercise, especially when metformin alone or dual therapy inadequately controls glycemia. Primary uses include newly diagnosed patients needing intensification, those with obesity (due to weight loss from glycosuria), and high-risk cardiovascular profiles benefiting from empagliflozin's heart protection. It excels in managing postprandial hyperglycemia, fasting glucose, and preventing complications like nephropathy.\n\n\nPrescribed for patients intolerant to other agents or requiring simplified regimens, it suits Indian demographics with high metabolic syndrome rates. Not for type 1 diabetes or ketoacidosis; renal function (eGFR >45 mL/min) guides initiation.\n\n\nKey Benefits\nLINALIGIP EMPAMET offers multifaceted advantages for long-term diabetes management:\n\nSuperior Glycemic Control: Achieves 1.8% HbA1c reduction in trials, outperforming monotherapies by targeting multiple defects.\n\n\nWeight Loss: Empagliflozin induces 3-5kg loss via caloric excretion, countering metformin's neutral effect.\n\n\nCardiovascular and Renal Protection: Reduces major adverse cardiac events (MACE) by 14% and slows CKD progression, per EMPA-REG outcomes.\n\n\nLow Hypoglycemia Risk: Glucose-dependent actions of linagliptin and empagliflozin minimize lows, unlike sulfonylureas.\n\n\nConvenience: Single-tablet ER dosing improves compliance, vital for busy lifestyles in Jaipur and beyond.\n\n\nBlood Pressure Reduction: Mild diuretic effect lowers systolic BP by 3-5 mmHg.\n\n\nThese benefits enhance quality of life, reducing fatigue, neuropathy risks, and healthcare costs.\n\nSide Effects\nCommon side effects mirror individual components but occur less due to synergy:\n\nGastrointestinal: Metformin ER causes less nausea/diarrhea (10-15%) than IR forms; titrate slowly.\n\n\nGenitourinary: Empagliflozin raises UTI/genital mycotic infection risk (5-10%), managed with hygiene.\n\n\nVolume Depletion: Orthostatic hypotension in 2-3%, especially with diuretics.\n\n\nSerious effects include lactic acidosis (rare, <1/100,000 with metformin in eGFR >30), ketoacidosis (euglycemic, 0.1%), and acute kidney injury. Monitor for dehydration, pancreatitis signs, or bullous pemphigoid with linagliptin. Hypersensitivity rash or bone fractures warrant discontinuation.\n\n\nSide Effect Category\tFrequency\tManagement\nNausea and Diarrhea\tCommon (10%)\tTake with food, slow titration \n\nUTI/Mycotic Infections\tCommon (7%)\tHydration, antifungals \n\nHypoglycemia\tRare (<2%)\tWith insulin, dose adjust \n\nLactic Acidosis\tVery Rare.\tAvoid in renal/hepatic failure \n\nKetoacidosis\tRare (0.1%)\tCheck ketones if nausea \n\nDosage and Administration\nStart with Empagliflozin 10mg/Linagliptin 5mg/Metformin ER 1000mg once daily with morning meal to optimize absorption and reduce GI effects. Titrate metformin to 2000mg max based on tolerance; empagliflozin to 25mg if needed. Swallow whole; no crushing. Adjust for renal impairment (eGFR 30-45: max metformin 1000mg; <30 contraindicated). Elderly start low due to volume sensitivity.\n\n\nMissed dose: Take soon if less than 12 hours late; skip otherwise. Discontinue pre-surgery or contrast use.\n\nPrecautions and Warnings\nAssess eGFR before and 3-6 months after initiation; hold if <45. Caution in dehydration, heart failure, or liver disease risks lactic acidosis. Educate on ketoacidosis symptoms (nausea, fatigue) despite normal glucose. Avoid excessive alcohol; monitor BP in hypertensives. Pregnancy category D—use insulin instead. Breastfeeding is contraindicated.\n\n\nDrug interactions: Adding sulfonylureas/insulin heightens hypoglycemia; rifampin reduces linagliptin levels; ritonavir boosts empagliflozin exposure.\n\nFrequently Asked Questions\nWhat is LINALIGIP EMPAMET used for?\nControls type 2 diabetes via triple action on glucose excretion, incretins, and insulin sensitivity.\n\nDoes it cause weight gain?\nNo—it promotes 2-4 kg loss, unlike some antidiabetics.\n\n\nSafe for kidneys?\nRenal-protective; monitor eGFR.\n\n\nHypoglycemia risk?\nMinimal without sulfonylureas.\n\nConclusion\nLINALIGIP EMPAMET revolutionizes type 2 diabetes care with its potent, convenient triple therapy, delivering glycemic mastery, weight benefits, and cardioprotection unmatched by singles or duos. Backed by landmark trials, it empowers patients toward complication-free lives when integrated with lifestyle changes. Consult physicians for personalized dosing to harness its full potential safely.",
"price": 220.0,
"discountamount": 66.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2257,
"imageuri": "https://productimages.withfloats.com/actual/694e60c1db6d50f75e42e875.png",
"tileimageuri": "https://productimages.withfloats.com/tile/694e60c1db6d50f75e42e875.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2025-12-26T09:34:56.604Z",
"updatedon": "2026-03-13T10:59:31Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//empagliflozin-linagliptin-and-metformin/2257",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "LINALIGIP EMPAMET",
"category": "DIABETIC RANGE",
"tags": [
"empagliflozin 10 mg",
"empagliflozin 25 mg",
"empagliflozin 10 mg uses in hindi",
"empagliflozin 10 mg tablet.",
"type 2 diabetes mellitus.",
"linagliptin",
"Linagliptin 5 mg",
"linagliptin 5 mg uses",
"linagliptin tablet uses",
"Linagliptin 5 mg price",
"Empagliflozin, an SGLT2 inhibitor.",
"Metformin ER reduces hepatic glucose production and improves insulin.",
"LINALIGIP EMPAMET revolutionizes type 2 diabetes.",
"empagliflozin linagliptin and metformin tablets",
"empagliflozin linagliptin metformin combination tablet",
"empagliflozin linagliptin metformin tablets uses",
"empagliflozin linagliptin metformin triple combination",
"empagliflozin linagliptin metformin dosage strength",
"empagliflozin linagliptin metformin sustained release tablet",
"empagliflozin linagliptin metformin medicine for diabetes",
"empagliflozin linagliptin metformin tablet uses",
"empagliflozin linagliptin metformin benefits",
"empagliflozin linagliptin metformin for type 2 diabetes",
"empagliflozin linagliptin metformin blood sugar control",
"empagliflozin linagliptin metformin weight loss benefit",
"what is empagliflozin linagliptin metformin tablet",
"how does empagliflozin linagliptin metformin work",
"empagliflozin linagliptin metformin tablet price in india",
"empagliflozin linagliptin metformin tablet dosage",
"empagliflozin linagliptin metformin before or after food"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "6890aa548a215c65672372e1",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Empagliflozin and Linagliptin Tablets",
"description": "EMPATECH LINA 25/5 is a pharmaceutical tablet containing a combination of two active ingredients: Empagliflozin 25MG and Linagliptin 5MG. This medication is designed to help manage blood sugar levels in adults with type 2 diabetes mellitus. The combination works through complementary mechanisms to improve glycemic control more effectively than either drug alone. Empagliflozin is a sodium-glucose cotransporter-2 (SGLT2) inhibitor that promotes the excretion of excess glucose through urine, while Linagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor that enhances insulin secretion and suppresses glucagon release, particularly after meals. EMPATECH LINA 25/5 is generally prescribed alongside a balanced diet and regular exercise to optimize blood sugar management and reduce the risk of diabetes-related complications such as kidney damage, neuropathy, and cardiovascular issues.\n\nWhat is EMPATECH LINA 25/5?\n\nEMPATECH LINA 25/5 is a prescription medication combining Empagliflozin (25MG) and Linagliptin (5MG) tablets used to manage type 2 diabetes. It helps control elevated blood sugar levels by using dual actions — the removal of glucose via kidneys and improving pancreatic hormone responses. This combination aims to achieve better and sustained glycemic control, often necessary for patients who have inadequate blood sugar control with other treatments.\n\nUses of EMPATECH LINA 25/5\n\nTo improve blood sugar control in adults with type 2 diabetes, particularly when monotherapy is insufficient.\n\nOften used as a second-line therapy after metformin or when metformin is not tolerated.\n\nTo reduce HbA1c (hemoglobin A1c), an important measure of long-term glucose control.\n\nMay help reduce weight and blood pressure as empagliflozin aids in glucose excretion.\n\nSupports comprehensive diabetes management along with diet and exercise.\n\nPrevents or reduces the risk of diabetes-associated complications such as kidney disease, cardiovascular events, and nerve damage.\n\nSide Effects of EMPATECH LINA 25/5\n\nCommon side effects may include urinary tract infections and genital infections due to increased glucose in urine.\n\nIncreased urination and dehydration.\n\nDizziness or lightheadedness, especially when standing up quickly.\n\nHypoglycemia (low blood sugar), though rare with this combination.\n\nGastrointestinal symptoms such as nausea or diarrhea.\n\nPotential increased risk of ketoacidosis (a serious condition related to high blood acids) in rare cases.\n\nAllergic reactions, although uncommon, may occur and require prompt medical attention.\n\nPrecautions Before Using EMPATECH LINA 25/5\n\nInform your healthcare provider if you have kidney disease, liver problems, or a history of urinary tract infections.\n\nNot recommended for type 1 diabetes or diabetic ketoacidosis treatment.\n\nUse with caution if you are pregnant, planning to become pregnant, or breastfeeding.\n\nStay hydrated while on this medication to reduce the risk of dehydration and dizziness.\n\nInform your doctor about any history of pancreatitis or pancreas disorders.\n\nRegular monitoring of kidney function and blood sugar levels is advised during treatment.\n\nAvoid drinking excessive alcohol as it may increase side effects or risk of ketoacidosis.\n\nDrug Interactions: What Drugs Interact with EMPATECH LINA 25/5?\n\nOther antidiabetic medications, such as insulin or sulfonylureas, may increase the risk of hypoglycemia.\n\nDiuretics, blood pressure medications, and lithium may interact and increase side effects.\n\nDrugs that impair kidney function can affect empagliflozin’s efficacy and safety.\n\nCertain enzyme-inducing drugs may reduce linagliptin levels, lowering its effectiveness.\n\nConsult your healthcare provider for a full list of possible interactions and before starting any new medication, including over-the-counter drugs or supplements.\n\nConclusion\n\nEMPATECH LINA 25/5, containing Empagliflozin 25MG and Linagliptin 5MG, is an effective combination medication to treat high blood sugar levels caused by type 2 diabetes. Its dual-action approach targets different physiological mechanisms to improve blood glucose control, helping reduce the risks and complications associated with diabetes. While it is generally well-tolerated, awareness of possible side effects and drug interactions is important. Always use under medical supervision, alongside lifestyle modifications such as diet and exercise, for optimal diabetes management.",
"price": 324.0,
"discountamount": 97.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2154,
"imageuri": "https://productimages.withfloats.com/actual/69de144aff27708f32d3a9ea.png",
"tileimageuri": "https://productimages.withfloats.com/tile/69de144aff27708f32d3a9ea.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2025-08-04T12:40:52.619Z",
"updatedon": "2026-05-23T07:06:09.535Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//empagliflozin-and-linagliptin-tablets/2154",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "EMPATECH LINA 25/5",
"category": "DIABETIC RANGE",
"tags": [
"Empagliflozin and Linagliptin Tablets",
"help manage blood sugar levels",
"2 diabetes mellitus",
"Empagliflozin is a sodium-glucose cotransporter-2 (SGLT2)",
"fixed dose combination of empagliflozin and linagliptin tablets",
"empagliflozin and linagliptin tablets uses",
"empagliflozin and linagliptin tablets 25 mg",
"empagliflozin 25 mg uses in hindi",
"empagliflozin side effects",
"fixed dose combination of empagliflozin and linagliptin tablets",
"empagliflozin and linagliptin tablets uses",
"empagliflozin and linagliptin uses in hindi",
"empagliflozin and linagliptin uses",
"fixed dose combination of empagliflozin and linagliptin tablets",
"empagliflozin and linagliptin",
"empagliflozin and linagliptin brands in india",
"empagliflozin and linagliptin tablets uses",
"empagliflozin and linagliptin brands",
"empagliflozin and linagliptin tablet uses",
"empagliflozin and linagliptin combination",
"combination of empagliflozin and linagliptin",
"empagliflozin and linagliptin tablet"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.001,
"isnotforsale": false
},
{
"_id": "6810aa8d5a26e4010ea41a99",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Empagliflozin 12.5mg ,Metformin Hydrochloride 500mg",
"description": "EMPATECH MET 12.5/500 is a powerful oral antidiabetic combination therapy containing Empagliflozin and Metformin Hydrochloride, designed to manage Type 2 Diabetes Mellitus effectively. This dual-action formula helps control blood sugar levels, supports weight management, and offers added cardiovascular benefits. EMPATECH MET 12.5/500 is particularly beneficial for adults who require a second-line treatment when diet, exercise, and monotherapy are not sufficient.\n\nKey Ingredients\nEmpagliflozin (12.5 mg):\nA sodium-glucose co-transporter-2 (SGLT2) inhibitor that helps reduce blood glucose levels by promoting glucose excretion through urine.\n\nMetformin Hydrochloride (500 mg):\nA biguanide class medication that lowers blood glucose by improving insulin sensitivity and reducing glucose production in the liver.\n\nKey Benefits\nHelps in lowering and maintaining stable blood glucose levels\n\nPromotes weight loss and reduces visceral fat\n\nReduces the risk of cardiovascular complications in diabetic patients\n\nSupports renal protection in people with diabetes and mild kidney dysfunction\n\nOffers a low risk of hypoglycemia compared to some other therapies\n\nImproves glycemic control with a dual mechanism of action\n\nHow Does It Work?\nEMPATECH MET 12.5/500 functions through two complementary mechanisms:\n\nEmpagliflozin works by blocking SGLT2 proteins in the kidneys, reducing the reabsorption of glucose and increasing its excretion via urine. This lowers blood sugar levels independently of insulin action.\n\nMetformin acts primarily by inhibiting hepatic glucose production and improving the body’s sensitivity to insulin, allowing for better uptake and usage of glucose by muscles and fat tissues.\n\nTogether, they provide a comprehensive glycemic control strategy, especially for patients not responding well to monotherapy.\n\nDirections for Use\nTake the tablet as prescribed by your doctor, usually once or twice daily with meals.\n\nSwallow the tablet whole with water; do not crush or chew.\n\nContinue following a healthy diet and regular exercise routine for optimal results.\n\nMonitor blood sugar levels regularly and report any unusual changes to your healthcare provider.\n\nDo not stop the medication without medical advice, even if your blood sugar levels improve.\n\nSide Effects\nCommon Side Effects:\n\nIncreased urination\n\nThirst or dry mouth\n\nNausea or mild gastrointestinal upset\n\nHeadache\n\nFatigue\n\nLess Common but Serious Side Effects:\n\nRisk of urinary tract infections or genital infections\n\nLactic acidosis (rare but serious; associated with Metformin)\n\nDehydration or low blood pressure, especially in elderly patients\n\nElectrolyte imbalances\n\nSeek immediate medical help if you experience severe abdominal pain, muscle cramping, breathing difficulties, or unusual tiredness.",
"price": 155.0,
"discountamount": 47.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": [
"unusual tiredness",
"medical advice",
"monotherapy directions",
"healthcare provider",
"healthy diet",
"chew continue",
"meals swallow",
"fat tissues",
"dual mechanism",
"hypoglycemia compared",
"cardiovascular complications",
"secondline treatment",
"metformin dehydration",
"insulin allowing",
"bodys sensitivity",
"kidneys reducing",
"low risk",
"diet exercise",
"improving insulin sensitivity",
"promoting glucose excretion",
"reducing glucose production",
"side effects risk",
"biguanide class medication",
"lowers blood glucose",
"low blood pressure",
"regular exercise routine",
"metformin hydrochloride designed",
"urinary tract infections",
"dry mouth nausea",
"blocking sglt2 proteins"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2093,
"imageuri": "https://productimages.withfloats.com/actual/6810aa8f5c4a4ba3d41a8c35.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6810aa8f5c4a4ba3d41a8c35.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2025-04-29T10:31:41.504Z",
"updatedon": "2026-04-15T06:40:21.664Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//empagliflozin-12-5mg-metformin-hydrochloride-500mg/2093",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "EMPATECH MET",
"category": "DIABETIC RANGE",
"tags": [
"empagliflozin 12.5 mg+metformin 500 mg price",
"empagliflozin 12.5 mg+metformin 1000 mg",
"empagliflozin 12.5mg brands in india",
"empagliflozin metformin hydrochloride",
"buy empagliflozin metformin hydrochloride",
"empagliflozin metformin hydrochloride tablet",
"buy empagliflozin metformin hydrochloride online"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.001,
"isnotforsale": false
},
{
"_id": "67a35d815432f8f0afe662b4",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "empagliflozin 25mg+ metformin hydrochloride (extended release) 1000 mg",
"description": "GLIEMPAFLOZIN MET ER is a combination medication used to manage type 2 diabetes mellitus (T2DM) by helping control blood sugar levels effectively. It contains two powerful anti-diabetic agents, Empagliflozin and Metformin Hydrochloride (Extended Release), which work together to enhance glucose regulation and reduce the risk of diabetes-related complications. This medication is recommended for patients who require additional glycemic control beyond lifestyle changes and monotherapy treatments.\n\n \nKey Benefits\n \n\n Effective Blood Sugar Control – Helps reduce and maintain optimal blood glucose levels in type 2 diabetic patients.\nWeight Management – Empagliflozin promotes caloric loss through urinary glucose excretion, potentially aiding in weight reduction.\nReduced Risk of Cardiovascular Diseases – Beneficial for heart health, lowering the risk of cardiac complications in diabetic patients.\nInsulin Sensitivity Improvement – Metformin enhances insulin function, reducing insulin resistance.\nLower Risk of Hypoglycemia – A balanced mechanism of action ensures stable blood glucose levels without sudden drops.\nKidney Protection – Empagliflozin may help protect against diabetic nephropathy by reducing kidney stress.\nExtended-Release Formula – Ensures long-lasting blood sugar control with a once-daily dosage for improved patient compliance.\n \nHow Does It Work?\n \n\nEmpagliflozin (SGLT2 Inhibitor) – Blocks the SGLT2 protein in the kidneys, preventing glucose reabsorption and promoting its excretion through urine, thereby reducing blood sugar levels.\nMetformin Hydrochloride (Biguanide) – Reduces glucose production in the liver, enhances insulin response, and delays glucose absorption in the digestive tract.\nTogether, they provide a dual action approach for better glycemic control while minimizing side effects like hypoglycemia.\n \nDirections for Use\n \n\nDosage: Take one tablet per day, preferably with food or as directed by your healthcare provider.\nSwallow whole with a glass of water; do not crush or chew.\n Maintain a healthy diet and follow a regular exercise routine for optimal results.\nRegular monitoring of blood sugar levels is advised.\nDo not stop taking this medication without consulting your doctor.\n\n \nSide Effects:\n \n\nSome individuals may experience mild to moderate side effects, including:\n\nFrequent urination (due to glucose excretion)\nDehydration (increased fluid loss)\nNausea, vomiting, or stomach upset\nDiarrhea or constipation\nMetallic taste in the mouth\nLow blood pressure (Hypotension)\nVitamin B12 deficiency (with long-term use of Metformin)\nUrinary tract infections (UTIs) or genital infections\n Seek medical attention if you experience severe allergic reactions, extreme dizziness, or difficulty breathing.",
"price": 245.0,
"discountamount": 74.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": [
"combination medication",
"hypoglycemia directions",
"oncedaily dosage",
"difficulty breathing",
"experience mild",
"stop taking",
"healthy diet",
"chew maintain",
"day preferably",
"glycemic control",
"digestive tract",
"sglt2 protein",
"diabetic nephropathy",
"balanced mechanism",
"cardiac complications",
"diabetesrelated complications",
"constipation metallic taste",
"stomach upset diarrhea",
"frequent urination due",
"moderate side effects",
"doctor side effects",
"blood sugar levels",
"regular exercise routine",
"healthcare provider swallow",
"minimizing side effects",
"dual action approach",
"delays glucose absorption",
"improved patient compliance",
"heart health lowering",
"cardiovascular diseases beneficial",
"enhance glucose regulation"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2049,
"imageuri": "https://productimages.withfloats.com/actual/67a35d9d1b599c6f20ba1fa7.png",
"tileimageuri": "https://productimages.withfloats.com/tile/67a35d9d1b599c6f20ba1fa7.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2025-02-05T12:45:53.712Z",
"updatedon": "2026-03-13T09:40:39.481Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//empagliflozin-25mg-metformin-hydrochloride-extended-release-1000-mg/2049",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "GLIEMPAFLOZIN MET ER ",
"category": "DIABETIC RANGE",
"tags": [
"empagliflozin/metformin 5 mg/1000 mg",
"empagliflozin + metformin brand name in india",
"empagliflozin + metformin combination brand name",
"empagliflozin 12.5 mg+metformin 500 mg price",
"Empagliflozin and metformin hydrochloride extended-release tablets",
"Empagliflozin and metformin hydrochloride tablets"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.001,
"isnotforsale": false
},
{
"_id": "67a35925da7066e27fe83d3a",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Empagliflozin 10 mg, Linagliptin5 mg",
"description": "GLIEMPAFLOZIN LINA is an advanced oral antidiabetic medication that combines Empagliflozin (10 mg) and Linagliptin (5 mg) to effectively manage Type 2 Diabetes Mellitus (T2DM). This combination helps regulate blood sugar levels while offering cardiovascular and renal benefits. It is a dual-action therapy that enhances insulin secretion and promotes glucose excretion, making it an excellent choice for diabetes control.\n\n \nKey Benefits:\n \n\nEffective Blood Sugar Control: Helps lower and maintain optimal blood glucose levels in patients with Type 2 Diabetes.\nDual Mechanism Action: Targets different pathways to improve insulin response and reduce glucose reabsorption.\nWeight Management Support: May aid in weight loss by eliminating excess glucose from the body.\nHeart and Kidney Protection: Reduces cardiovascular risks and provides potential renal protection for diabetic patients.\nConvenient Dosing: Single-tablet formulation for ease of administration and better patient adherence.\n \nHow Does It Work?\n \n\nGLIEMPAFLOZIN LINA works through a dual mechanism:\nEmpagliflozin blocks the SGLT2 transporter in the kidneys, preventing glucose reabsorption and increasing its elimination through urine. This helps lower blood sugar levels and reduces the risk of cardiovascular complications.\n\nLinagliptin inhibits DPP-4 enzyme activity, thereby increasing incretin hormone levels. This leads to increased insulin secretion and decreased glucagon production, ensuring better glucose metabolism.\n\n \nDirections for Use:\n \n\nTake one tablet daily or as prescribed by your healthcare provider.\n\nCan be taken with or without food.\n\nMaintain a healthy diet and regular exercise routine for optimal results.\n\nDo not crush, chew, or break the tablet; swallow it whole with water.\n\n \nSide Effects:\n \n\nWhile GLIEMPAFLOZIN LINA is well-tolerated, some individuals may experience:\n\nFrequent urination due to increased glucose excretion.\n\nMild dehydration or increased thirst.\n\nHypoglycemia (low blood sugar), especially when combined with insulin or sulfonylureas.\n\nUrinary tract infections (UTIs) or genital yeast infections.\n\nAllergic reactions, such as rash or itching (rare).\n\nDigestive discomfort, including nausea or diarrhea.",
"price": 315.0,
"discountamount": 95.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": [
"gliempaflozin lina",
"tablet swallow",
"crush chew",
"optimal results",
"healthy diet",
"food maintain",
"healthcare provider",
"tablet daily",
"sglt2 transporter",
"patient adherence",
"body heart",
"weight loss",
"excellent choice",
"dualaction therapy",
"offering cardiovascular",
"linagliptin 5 mg",
"renal benefits",
"increased insulin secretion",
"potential renal protection",
"improve insulin response",
"enhances insulin secretion",
"water side effects",
"regular exercise routine",
"glucose metabolism directions",
"eliminating excess glucose"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2045,
"imageuri": "https://productimages.withfloats.com/actual/67a35955c525b12e62733a1a.png",
"tileimageuri": "https://productimages.withfloats.com/tile/67a35955c525b12e62733a1a.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2025-02-05T12:27:17.266Z",
"updatedon": "2026-03-13T09:34:23.299Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//empagliflozin-10-mg-linagliptin5-mg/2045",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "GLIEMPAFLOZIN LINA 10MG/ 5MG ",
"category": "DIABETIC RANGE",
"tags": [
"empagliflozin-linagliptin 25-5 mg",
"Empagliflozin/linagliptin side effects",
"Linagliptin empagliflozin combination brand name",
"empagliflozin-linagliptin 25-5 mg price",
"Empagliflozin and Linagliptin brands in India"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.001,
"isnotforsale": false
},
{
"_id": "67a35691f802c88560805614",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Empagliflozin 10mg",
"description": "GLIEMPAFLOZIN 10 is a prescription medication containing Empagliflozin (10mg), a highly effective oral antidiabetic drug used to manage type 2 diabetes mellitus (T2DM). It belongs to the class of SGLT2 inhibitors (Sodium-Glucose Co-Transporter 2 Inhibitors) and helps lower blood sugar levels by promoting glucose excretion through urine. This medication is designed to improve glycemic control in adults with diabetes while also offering cardiovascular and renal benefits.\n\n \nKey Benefits:\n \n\nEffective Blood Sugar Control: Helps reduce HbA1c levels, leading to better diabetes management.\n\nWeight Management: May contribute to weight loss by eliminating excess glucose through urine.\n\nHeart Health Benefits: Reduces the risk of cardiovascular complications in diabetic patients.\n\nKidney Protection: Helps in slowing the progression of diabetic nephropathy, offering renal protective benefits.\n\nLower Risk of Hypoglycemia: Since it works independently of insulin, it has a lower risk of causing low blood sugar episodes.\n\nImproves Insulin Sensitivity: Enhances glucose utilization by the body, promoting better metabolic health.\n\n \nHow Does It Work?\n \n\nGLIEMPAFLOZIN 10 functions by inhibiting the SGLT2 protein in the kidneys. Normally, this protein facilitates glucose reabsorption in the renal tubules, preventing it from being expelled through urine. By blocking SGLT2, Empagliflozin prevents glucose reabsorption, leading to increased glucose excretion and lower blood sugar levels. Additionally, it reduces blood pressure, body weight, and the risk of cardiovascular diseases, making it a comprehensive treatment option for diabetes.\n\n \nDirections for Use:\n \n\nTake one tablet of GLIEMPAFLOZIN 10 once daily, with or without food, as prescribed by your doctor.\n\nSwallow the tablet whole with a glass of water.\n\nFollow a healthy diet and regular exercise routine alongside medication for optimal results.\n\nDo not skip doses or stop taking the medication without consulting your healthcare provider.\n\n \nSide Effects:\n \n\nWhile GLIEMPAFLOZIN 10 is well-tolerated, some individuals may experience mild to moderate side effects, including:\n\nFrequent urination due to increased glucose excretion.\n\nDehydration and dizziness, especially in hot weather or when not drinking enough fluids.\n\nUrinary tract infections (UTIs) or genital yeast infections due to higher sugar levels in urine.\n\nLow blood pressure (hypotension) in some patients.\n\nIncreased cholesterol levels in certain cases.\n\nKetoacidosis (rare but serious), which requires immediate medical attention.",
"price": 135.0,
"discountamount": 41.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": [
"gliempaflozin 10",
"lower risk",
"prescription medication",
"diabetes directions",
"medical attention",
"hot weather",
"experience mild",
"stop taking",
"skip doses",
"optimal results",
"healthy diet",
"water follow",
"doctor swallow",
"sglt2 protein",
"metabolic health",
"works independently",
"weight loss",
"empagliflozin 10mg",
"empagliflozin 10mggliempaflozin 10",
"cardiovascular complications",
"offering cardiovascular",
"body promoting",
"cardiovascular diseases making",
"promoting glucose excretion",
"cases ketoacidosis rare",
"higher sugar levels",
"frequent urination due",
"moderate side effects",
"comprehensive treatment option",
"increased glucose excretion",
"renal tubules preventing",
"eliminating excess glucose",
"improve glycemic control"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2042,
"imageuri": "https://productimages.withfloats.com/actual/67a356d6b85688fc926014bf.png",
"tileimageuri": "https://productimages.withfloats.com/tile/67a356d6b85688fc926014bf.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2025-02-05T12:16:17.708Z",
"updatedon": "2026-03-13T09:31:13.997Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//empagliflozin-10mg/2042",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "GLIEMPAFLOZIN 10 ",
"category": "DIABETIC RANGE",
"tags": [
"Empagliflozin 10mg price",
"Empagliflozin 10 mg brand name",
"Empagliflozin 10 mg brands in India",
"Empagliflozin side effects",
"Empagliflozin 10 mg vs 25 mg efficacy"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.001,
"isnotforsale": false
},
{
"_id": "668e72553345171da8e569d1",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Divalproex 250mg/5ml",
"description": "DIOWELPREX 250 ORAL SOLUTION \nDivalproex (250mg/5ml)\nIntroduction\nDIOWELPREX 250 ORAL SOLUTION contains Divalproex (250mg/5ml), an anticonvulsant and mood-stabilizing medication used to treat various neurological and psychiatric conditions. It is particularly effective in managing epilepsy, bipolar disorder, and preventing migraine headaches.\n\nComposition\n\nDivalproex Sodium (250mg/5ml): A stable coordination compound comprised of sodium valproate and valproic acid in a 1:1 molar relationship, providing a source of valproate ion which exhibits anticonvulsant and mood-stabilizing properties.\nMechanism of Action\nDivalproex works by increasing the levels of gamma-aminobutyric acid (GABA) in the brain, an inhibitory neurotransmitter that helps calm neuronal activity. It stabilizes electrical activity in the brain, reducing the frequency and severity of seizures, stabilizing mood in bipolar disorder, and preventing migraine headaches by altering the way nerves send signals.\n\nIndications\nDIOWELPREX 250 ORAL SOLUTION is indicated for:\n\nEpilepsy: Used to control various types of seizures including complex partial seizures and simple and complex absence seizures.\nBipolar Disorder: Helps in the management of manic episodes associated with bipolar disorder.\nMigraine Prophylaxis: Used to prevent migraine headaches.\nDosage and Administration\n\nEpilepsy: The initial dose is typically 10-15 mg/kg/day, gradually increased as needed and tolerated to achieve optimal clinical response.\nBipolar Disorder: The initial dose is generally 750 mg/day, given in divided doses, adjusted according to clinical response.\nMigraine Prophylaxis: The initial dose is usually 250 mg twice daily, adjusted as necessary.\nIt is essential to follow the prescribed dosage and administration instructions provided by a healthcare professional. The oral solution should be measured accurately using a dosing syringe or cup to ensure the correct dose is administered.\nSide Effects\nCommon side effects may include:\n\nNausea\nDrowsiness\nDizziness\nTremor\nHair loss\nWeight gain\nGastrointestinal disturbances\nMore severe side effects can include:\n\nLiver damage\nPancreatitis\nThrombocytopenia (low platelet count)\nHyperammonemia (high levels of ammonia in the blood)\nPrecautions\n\nLiver Function: Regular monitoring of liver function tests is recommended due to the risk of hepatotoxicity.\nPancreatitis: Patients should be monitored for signs of pancreatitis.\nPregnancy: Divalproex is associated with an increased risk of congenital malformations and should be used during pregnancy only if absolutely necessary and prescribed by a healthcare provider.\nBleeding Disorders: Caution is advised in patients with known bleeding disorders due to the risk of thrombocytopenia.\nDrug Interactions\n\nAntiepileptic Drugs: Concurrent use with other antiepileptic drugs may require dosage adjustments.\nWarfarin: May enhance the anticoagulant effect, necessitating close monitoring of INR levels.\nTopiramate: Co-administration can lead to hyperammonemia and encephalopathy.\nAlcohol: Should be avoided as it can exacerbate the side effects of Divalproex and further impair mental and motor skills.\nConclusion\nDIOWELPREX 250 ORAL SOLUTION is an effective medication for managing epilepsy, bipolar disorder, and preventing migraines. With its active ingredient Divalproex, it helps stabilize neuronal activity and mood. Proper dosage and administration under the guidance of a healthcare professional are essential to maximize benefits and minimize potential side effects. Regular monitoring and adherence to medical advice ensure the safe and effective use of DIOWELPREX 250 ORAL SOLUTION.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\n",
"price": 445.0,
"discountamount": 133.5,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 7,
"_keywords": [
"250 mg",
"750 mg",
"10-15 mg",
"Hair loss",
"INR levels",
"high levels",
"Weight gain",
"motor skills",
"correct dose",
"initial dose",
"Liver damage",
"Proper dosage",
"effective use",
"divided doses",
"various types",
"valproate ion",
"valproic acid",
"increased risk",
"medical advice",
"Concurrent use",
"dosing syringe",
"manic episodes",
"close monitoring",
"sodium valproate",
"bipolar disorder",
"Divalproex Sodium",
"active ingredient",
"Drug Interactions",
"neuronal activity",
"dosage adjustments",
"Bleeding Disorders",
"Regular monitoring",
"migraine headaches",
"low platelet count",
"healthcare provider",
"electrical activity",
"Common side effects",
"effective medication",
"anticoagulant effect",
"Migraine Prophylaxis",
"various neurological",
"liver function tests",
"1:1 molar relationship",
"psychiatric conditions",
"potential side effects",
"healthcare professional",
"gamma-aminobutyric acid",
"congenital malformations",
"complex absence seizures",
"complex partial seizures",
"More severe side effects",
"other antiepileptic drugs",
"optimal clinical response",
"administration instructions",
"inhibitory neurotransmitter",
"mood-stabilizing properties",
"mood-stabilizing medication",
"DIOWELPREX 250 ORAL SOLUTION",
"stable coordination compound",
"Gastrointestinal disturbances"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 1933,
"imageuri": "https://productimages.withfloats.com/actual/668e72573a68154e11e7951b.jpeg",
"tileimageuri": "https://productimages.withfloats.com/tile/668e72573a68154e11e7951b.jpeg",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2024-07-10T11:36:53.173Z",
"updatedon": "2026-03-12T11:53:40.512Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//divalproex-250mg-5ml/1933",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "DIOWELPREX 250 ORAL SOLUTION ",
"category": "NEUROLOGY RANGE",
"tags": [
"Divalproex 250 mg",
"Divalproex side effects",
"Divalproex prolonged release tablets",
"Divalproex extended release tablets IP 250 mg",
"Divalproex prolonged release tablets uses",
"Divalproex 250 mg side effects",
""
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": "",
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.001,
"isnotforsale": false
}
],
"hasmoreitems": false,
"isapirequest": false,
"totalresults": 27,
"query": null,
"floatingpoint": null
}